Christian Clemm von Hohenberg1, Ofer Pasternak2, Marek Kubicki3, Thomas Ballinger4, Mai-Anh Vu4, Tali Swisher4, Katie Green4, Michelle Giwerc4, Brian Dahlben4, Jill M Goldstein5, Tsung-Ung W Woo6, Tracey L Petryshen7, Raquelle I Mesholam-Gately8, Kristen A Woodberry8, Heidi W Thermenos9, Christoph Mulert10, Robert W McCarley11, Larry J Seidman9, Martha E Shenton12. 1. clemm@bwh.harvard.edu. 2. Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Psychiatry, Harvard Medical School, Boston, MA; 3. Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Psychiatry, Harvard Medical School, Boston, MA; Department of Radiology, Harvard Medical School, Boston, MA; 4. Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; 5. Department of Psychiatry, Harvard Medical School, Boston, MA; Departments of Psychiatry and Medicine, Connors Center for Women's Health and Gender Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; 6. Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA; 7. Department of Psychiatry, Harvard Medical School, Boston, MA; Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research and Department of Psychiatry, Massachusetts General Hospital, Boston, MA; 8. Department of Psychiatry, Harvard Medical School, Boston, MA; Massachusetts Mental Health Center, Public Psychiatry Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; 9. Department of Psychiatry, Harvard Medical School, Boston, MA; 10. Psychiatry Neuroimaging Branch, Imaging Center NeuroImage Nord and Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 11. Department of Psychiatry, Harvard Medical School, Boston, MA; Clinical Neuroscience Division, Laboratory of Neuroscience, Veterans Affairs Boston Healthcare System, Brockton Division, Brockton, MA. 12. Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Psychiatry, Harvard Medical School, Boston, MA; Department of Radiology, Harvard Medical School, Boston, MA; Clinical Neuroscience Division, Laboratory of Neuroscience, Veterans Affairs Boston Healthcare System, Brockton Division, Brockton, MA.
Abstract
BACKGROUND: The study of individuals at clinical high risk (CHR) for psychosis provides an important opportunity for unraveling pathological mechanisms underlying schizophrenia and related disorders. A small number of diffusion tensor magnetic resonance imaging (DTI) studies in CHR samples have yielded anatomically inconsistent results. The present study is the first to apply tract-based spatial statistics (TBSS) to perform a whole-brain DTI analysis in CHR subjects. METHODS: A total of 28 individuals meeting CHR criteria and 34 healthy controls underwent DTI. TBSS was used for a group comparison of fractional anisotropy (FA), as well as axial, radial, and mean diffusivity (AD, RD, and MD). Conversion to psychosis was monitored during a mean follow-up period of 12.3 months. RESULTS: The rate of conversion to psychosis was relatively low (4%). TBSS revealed increased MD in several clusters in the right hemisphere, most notably in the superior longitudinal fasciculus (SLF), posterior corona radiata, and corpus callosum (splenium and body). Increased RD was restricted to a smaller area in the posterior parietal lobe. CONCLUSION: We present further evidence that white matter microstructure is abnormal in CHR individuals, even in a sample in which the vast majority do not transition to psychosis over the following year. In accord with previous studies on CHR individuals and patients with early-onset schizophrenia, our findings suggest an important pathological role for the parietal lobe and especially the SLF. The latter is known to undergo particularly dynamic microstructural changes during adolescence and early adulthood, a critical phase for the development of psychotic illness.
BACKGROUND: The study of individuals at clinical high risk (CHR) for psychosis provides an important opportunity for unraveling pathological mechanisms underlying schizophrenia and related disorders. A small number of diffusion tensor magnetic resonance imaging (DTI) studies in CHR samples have yielded anatomically inconsistent results. The present study is the first to apply tract-based spatial statistics (TBSS) to perform a whole-brain DTI analysis in CHR subjects. METHODS: A total of 28 individuals meeting CHR criteria and 34 healthy controls underwent DTI. TBSS was used for a group comparison of fractional anisotropy (FA), as well as axial, radial, and mean diffusivity (AD, RD, and MD). Conversion to psychosis was monitored during a mean follow-up period of 12.3 months. RESULTS: The rate of conversion to psychosis was relatively low (4%). TBSS revealed increased MD in several clusters in the right hemisphere, most notably in the superior longitudinal fasciculus (SLF), posterior corona radiata, and corpus callosum (splenium and body). Increased RD was restricted to a smaller area in the posterior parietal lobe. CONCLUSION: We present further evidence that white matter microstructure is abnormal in CHR individuals, even in a sample in which the vast majority do not transition to psychosis over the following year. In accord with previous studies on CHR individuals and patients with early-onset schizophrenia, our findings suggest an important pathological role for the parietal lobe and especially the SLF. The latter is known to undergo particularly dynamic microstructural changes during adolescence and early adulthood, a critical phase for the development of psychotic illness.
Authors: Bart D Peters; Peter M Dingemans; Nienke Dekker; Jorik Blaas; Erik Akkerman; Therese A van Amelsvoort; Charles B Majoie; Gerard J den Heeten; Don H Linszen; Lieuwe de Haan Journal: Psychiatry Res Date: 2010-01-30 Impact factor: 3.222
Authors: Bart D Peters; Lieuwe de Haan; Nienke Dekker; Jorik Blaas; Hiske E Becker; Peter M Dingemans; Erik M Akkerman; Charles B Majoie; Therèse van Amelsvoort; Gerard J den Heeten; Don H Linszen Journal: Neuropsychobiology Date: 2008-09-10 Impact factor: 2.328
Authors: Francesco Carletti; James B Woolley; Sagnik Bhattacharyya; Rocio Perez-Iglesias; Paolo Fusar Poli; Lucia Valmaggia; Matthew R Broome; Elvira Bramon; Louise Johns; Vincent Giampietro; Steve C R Williams; Gareth J Barker; Philip K McGuire Journal: Schizophr Bull Date: 2012-04-03 Impact factor: 9.306
Authors: Vijay A Mittal; Derek J Dean; Jessica A Bernard; Joseph M Orr; Andrea Pelletier-Baldelli; Emily E Carol; Tina Gupta; Jessica Turner; Daniel R Leopold; Briana L Robustelli; Zachary B Millman Journal: Schizophr Bull Date: 2013-12-27 Impact factor: 9.306
Authors: Hidayet E Arat; Virginie-Anne Chouinard; Bruce M Cohen; Kathryn E Lewandowski; Dost Öngür Journal: Schizophr Res Date: 2014-12-24 Impact factor: 4.939
Authors: Zora Kikinis; Kang Ik K Cho; Ioana L Coman; Petya D Radoeva; Sylvain Bouix; Yingying Tang; Ryan Eckbo; Nikos Makris; Jun Soo Kwon; Marek Kubicki; Kevin M Antshel; Wanda Fremont; Martha E Shenton; Wendy R Kates Journal: Brain Imaging Behav Date: 2017-10 Impact factor: 3.978
Authors: Akvile Lukoshe; Gerbrich E van den Bosch; Aad van der Lugt; Steven A Kushner; Anita C Hokken-Koelega; Tonya White Journal: Schizophr Bull Date: 2017-09-01 Impact factor: 9.306
Authors: Katherine S F Damme; Tina Gupta; Robin Nusslock; Jessica A Bernard; Joseph M Orr; Vijay A Mittal Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2018-01-31
Authors: Pamela DeRosse; Toshikazu Ikuta; Katherine H Karlsgodt; Bart D Peters; Chaya B Gopin; Philip R Szeszko; Anil K Malhotra Journal: Schizophr Bull Date: 2016-05-17 Impact factor: 9.306
Authors: Philip R Szeszko; Ek Tsoon Tan; Aziz M Uluğ; Peter B Kingsley; Juan A Gallego; Kathryn Rhindress; Anil K Malhotra; Delbert G Robinson; Luca Marinelli Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2017-10-28 Impact factor: 5.067